Holdings
Prosight Management, LP
As of Jun 30, 2026, Prosight Management, LP reported 34 positions worth US$551M. Largest: Lakefront Biotherapeutics, Janux Therapeutics, Inc. and Nektar Therapeutics. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Lakefront Biotherapeutics | 2.04M | US$61.3M | +493K | Jun 30, 2026 |
| Janux Therapeutics, Inc. | 3.8M | US$58.4M | +254K | Jun 30, 2026 |
| Nektar Therapeutics | 810K | US$56.5M | +75,000 | Jun 30, 2026 |
| Boston Scientific Corporation | 1.27M | US$54.2M | +475K | Jun 30, 2026 |
| Shattuck Labs, Inc. | 5.96M | US$41.3M | +953K | Jun 30, 2026 |
| Insmed Incorporated | 376K | US$40M | new | Jun 30, 2026 |
| Alnylam Pharmaceuticals, Inc. | 98,080 | US$29.5M | +22,080 | Jun 30, 2026 |
| Syndax Pharmaceuticals, Inc. | 1.2M | US$26.2M | +430K | Jun 30, 2026 |
| Kura Oncology, Inc. | 2.02M | US$22.2M | −1.33M | Jun 30, 2026 |
| Irhythm Holdings, Inc. | 166K | US$19.7M | +156K | Jun 30, 2026 |